shopping cart Your cart is empty
  • Home
  • Medical Devices
  • Biopsy Devices Market By Product (Needle-Based, Biopsy Needles, Biopsy Forceps, Biopsy Guidance & Others), Industry Size, Growth,...

Biopsy Devices Market By Product (Needle-Based, Biopsy Needles, Biopsy Forceps, Biopsy Guidance & Others), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Feb 1, 2016

The global Biopsy devices market is expected to grow at the CAGR of 9% during 2015-2022 and it is estimated to be $XX billion by 2022. The global Biopsy market is segmented on the basis of products and geography.

The market is driven by increasing prevalence of cancer. There is constant need for high quality diagnostic and therapeutic processes. However, such unmet patient needs has forced the companies and governments to work in order to provide better services. Population aging is a major influence on patterns of health care spending in both developed and developing countries. In developed countries such as the U.S. and western European countries, where point of care healthcare services and institutional long-term care services and medcare policies are available. The proportion of aged people using healthcare services is high. The per capita health expenditure on healthcare is higher as compared to other age groups. There is constant pressure on the healthcare services as the number of older people increases. Such factors are driving the biopsy market.

Some of the restraints faced by the industry are High cost of procedures and instruments. Lack of proper trained professionals one of the major issues in the industry which is required to be solved soon.

 

Market segment insight

 

Biopsy market segments include major products such guidance systems, needle based guns, needles, and forceps. Guidance systems have the highest market share amongst all the product. During the year 2015 guidance systems segments had the largest market share of all the other biopsy products present in the market and it is expected that this segment would be maintaining its dominance in the biopsy market

 

Regional insight

 

North America hold the largest market share among the other regions followed by Europe. It is estimated that North America and Europe together have XX% of the total market share followed by Asia Pacific.

 

Competitive insight

 

Some of the major market players listed in the report are Angiotech, Boston Scientific, Cardinal Health, Carefusion Corp, etc. Innovation is the key strategy adopted in the Biopsy industry. Increase in the number of market players and adoption of more advanced methods as compared to the conventional ones are the key market trend of the industry.

 

Reasons for buying the report

 

  • This report provides a detailed study of current trends in the Biopsy industry, key growth drivers, and restraints.
  • It provides market forecast for the next 7 years (2015-2022) assessed on the basis of market growth.
  • The report also includes analysis of recent technological developments in the Biopsy market, analysis of key market players and the key winning strategy adopted and predictive analysis.
  • The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
  • The report tracks and analyse the changing market dynamics.
  • The report also talks about emerging opportunities in the market and the future impact of major drivers and restraints of the market.
  • The report also provides extensive analysis with respect to key product segments.
  • The analysis in the report will help in making effective business decisions.
  • It provides analysis through distinctive graphs and charts and analyses strengths, weakness, opportunities and threats of major market players.

1. METHODOLOGY & SCOPE 11
    1.1. Research Methodology 11
    1.2. Research Scope & Assumptions 11
    1.3. List of Data Sources 11

 

2. EXECUTIVE SUMMARY 11
    2.1. Global Biopsy market – Industry summary & key buying criteria 11
    2.2. Global Biopsy market – industry outlook 11

 

3. MARKET SEGMENTATION 11
    3.1. Market size and growth prospects 2012-2022 11
    3.2. Global Biopsy industry value chain analysis 11
    3.3. Vendor Landscape 11

 

4. GLOBAL BIOPSY MARKET DYNAMICS 11
    4.1. Market driver analysis 11
        4.1.1. Increasing prevalance of lifestyle and chronic diseases 11
        4.1.2. Minimally invasive procedures gaining popularity 11
        4.1.3. Rising healthcare expenditure 11
        4.1.4. Ageing population 11
    4.2. Market restraint analysis 11
        4.2.1. High cost 11
        4.2.2. Number of trained professionals in emerging economies 11
    4.3. Key opportunities prioritized 11
        4.3.1. Untapped emerging economies 11

 

5. INDUSTRY ANALYSIS – PORTER’S 11
    5.1. Global Biopsy market industry– PESTEL analysis 11

 

6. GLOBAL BIOPSY DEVICES MARKET BY PRODUCT 2012 – 2022 ($ BILLION) 11
    6.1. Global Needle-Based Biopsy Guns 2012 – 2022 ($ BILLION) 11
        6.1.1. Global Vacuum-Assisted Biopsy (VAB) Devices 2012 – 2022 ($ BILLION) 11
        6.1.2. Global Core Needle Biopsy (CNB) Devices 2012 – 2022 ($ BILLION) 12
        6.1.3. Global Fine Needle Aspiration Biopsy (FNAB) Devices 2012 – 2022 ($ BILLION) 12
    6.2. Global Biopsy Needles 2012 – 2022 ($ BILLION) 12
        6.2.1. Global Disposable Biopsy Needles 2012 – 2022 ($ BILLION) 12
        6.2.2. Global Reusable Biopsy Needles 2012 – 2022 ($ BILLION) 12
    6.3. Global Biopsy Forceps 2012 – 2022 ($ BILLION) 12
        6.3.1. Global Cold (General) Biopsy Forceps 2012 – 2022 ($ BILLION) 12
        6.3.2. Global Hot Biopsy Forceps 2012 – 2022 ($ BILLION) 12
    6.4. Global Biopsy Guidance Systems 2012 – 2022 ($ BILLION) 12
        6.4.1. Global Manual Guidance Systems 2012 – 2022 ($ BILLION) 12
        6.4.2. Global Robotic Guidance Systems 2012 – 2022 ($ BILLION) 12
    6.5. Global Others 2012 – 2022 ($ BILLION) 12
        6.5.1. Global Biopsy Brushes 2012 – 2022 ($ BILLION) 12
        6.5.2. Global Biopsy Curettes 2012 – 2022 ($ BILLION) 12
        6.5.3. Global Biopsy Punches 2012 – 2022 ($ BILLION) 12

 

7. GLOBAL BIOPSY MARKET, REGIONAL OUTLOOK 2012-2022 ($ BILLION) 12
    7.1. Global Biopsy market volume share by region 2012 – 2022 ($ BILLION) 12
    7.2. North America 12
        7.2.1. North America market estimates and forecast 2012 – 2022 ($ BILLION) 12
        7.2.2. North America market estimates and forecast by region 2012 – 2022 ($ BILLION) 12
        7.2.3. North America market estimates and forecast by application 2012 – 2022 ($ BILLION) 12
             7.2.3.1. US 12
                 7.2.3.1.1. US market estimates and forecast 2012 – 2022($ BILLION) 12
                 7.2.3.1.2. U.S. market estimates and forecast by application 2012 – 2022($ BILLION) 13
             7.2.3.2. Canada 13
                 7.2.3.2.1. Canada market estimates and forecast 2012 – 2022 ($ BILLION) 13
                 7.2.3.2.2. Canada market estimates and forecast by application 2012 – 2022 ($ BILLION) 13
            7.2.3.3. Mexico 13
                7.2.3.3.1. Mexico market estimates and forecast, 2012 – 2022($ BILLION) 13
                7.2.3.3.2. Canada market estimates and forecast by application 2012 – 2022 ($ BILLION) 13
    7.3. Europe 13
        7.3.1. Europe market estimates and forecast 2012–2022($ BILLION) 13
        7.3.2. Europe market estimates and forecast by region 2012–2022 ($ BILLION) 13
        7.3.3. Europe market estimates and forecast by application 2012 – 2022 ($ BILLION) 13
            7.3.3.1. Germany 13
                7.3.3.1.1. Germany market estimates and forecast 2012 – 2022 ($ BILLION) 13
                7.3.3.1.2. Germany market estimates and forecast by applicatio 2012 – 2022($ BILLION) 13
            7.3.3.2. UK 13
                7.3.3.2.1. UK market estimates and forecast 2012 – 2022 ($ BILLION) 13
                7.3.3.2.2. market estimates and forecast by application 2012 – 2022 ($ BILLION) 13
            7.3.3.3. Russia 13
                7.3.3.3.1. Russia market estimates and forecast 2012 – 2022 ($ BILLION) 13
                7.3.3.3.2. Russia market estimates and forecast by applicatioN 2012 – 2022 ($ BILLION) 14
    7.4. Asia Pacific 14
        7.4.1. Asia Pacific market estimates and forecast 2012 – 2022 ($ BILLION) 14
        7.4.2. Asia Pacific market estimates and forecast by region 2012 – 2022 ($ BILLION) 14
        7.4.3. Asia Pacific market estimates and forecast by application 2012 – 2022 ($ BILLION) 14
            7.4.3.1. China 14
                7.4.3.1.1. China market estimates and forecast 2012 – 2022 ($ BILLION) 14
                7.4.3.1.2. China market estimates and forecast by application 2012 – 2022 ($ BILLION) 14
            7.4.3.2. India 14
                7.4.3.2.1. India market estimates and forecast 2012 – 2022 ($ BILLION) 14
                7.4.3.2.2. India market estimates and forecast by application 2012 – 2022 ($ BILLION) 14
            7.4.3.3. South Korea 14
                 7.4.3.3.1. South Korea market estimates and forecast 2012 – 2022 ($ BILLION) 14
                 7.4.3.3.2. South Korea market estimates and forecast by application 2012 – 2022 ($ BILLION) 14
    7.5. Middle East & Africa 15
        7.5.1. Middle East & Africa market estimates and forecast 2012 – 2022 ($ BILLION) 15
        7.5.2. Middle East & Africa market estimates and forecast by application 2012 – 2022 ($ BILLION) 15
    7.6. Central &South America 15
        7.6.1. Central & South America market estimates and forecast 2012 – 2022 ($ BILLION) 15
        7.6.2. Central & South America market estimates and forecast by application 2012 – 2022 ($ BILLION) 15
            7.6.2.1. Brazil 15
                7.6.2.1.1. Brazil market estimates and forecast 2012 – 2022 ($ BILLION) 15
                7.6.2.1.2. Brazil market estimates and forecast by application 2012 – 2022 ($ BILLION) 15

 

8. COMPETITIVE LANDSCAPE 16
    8.1. Angiotech 16
        8.1.1. Company Overview 16
        8.1.2. Financial Performance 16
        8.1.3. Product Benchmarking 16
        8.1.4. Strategic Initiatives 16
    8.2. Boston Scientific 16
        8.2.1. Company Overview 16
        8.2.2. Financial Performance 16
        8.2.3. Product Benchmarking 16
        8.2.4. Strategic Initiatives 16
    8.3. Cardinal Health 16
        8.3.1. Company Overview 16
        8.3.2. Financial Performance 16
        8.3.3. Product Benchmarking 16
        8.3.4. Strategic Initiatives 16
    8.4. Carefusion Corp. 16
        8.4.1. Company Overview 16
        8.4.2. Financial Performance 16
        8.4.3. Product Benchmarking 16
        8.4.4. Strategic Initiatives 16
    8.5. Cook medical 16
        8.5.1. Company Overview 16
        8.5.2. Financial Performance 16
        8.5.3. Product Benchmarking 16
        8.5.4. Strategic Initiatives 16
    8.6. CR Bard 16
        8.6.1. Company Overview 16
        8.6.2. Financial Performance 16
        8.6.3. Product Benchmarking 16
        8.6.4. Strategic Initiatives 16
    8.7. Devicor 16
        8.7.1. Company Overview 16
        8.7.2. Financial Performance 16
        8.7.3. Product Benchmarking 16
        8.7.4. Strategic Initiatives 16
    8.8. DTR medical 17
        8.8.1. Company Overview 17
        8.8.2. Financial Performance 17
        8.8.3. Product Benchmarking 17
        8.8.4. Strategic Initiatives 17
    8.9. Ethicon 17
        8.9.1. Company Overview 17
        8.9.2. Financial Performance 17
        8.9.3. Product Benchmarking 17
       8.9.4. Strategic Initiatives 17
    8.10. Fujifilms Holdings Corp. 17
        8.10.1. Company Overview 17
        8.10.2. Financial Performance 17
        8.10.3. Product Benchmarking 17
        8.10.4. Strategic Initiatives 17
    8.11. Hologic 17
        8.11.1. Company Overview 17
        8.11.2. Financial Performance 17
        8.11.3. Product Benchmarking 17
        8.11.4. Strategic Initiatives 17
    8.12. Mauna KEA Technologies 17
        8.12.1. Company Overview 17
        8.12.2. Financial Performance 17
        8.12.3. Product Benchmarking 17
        8.12.4. Strategic Initiatives 17
    8.13. MDXHealth Inc. 17
        8.13.1. Company Overview 17
        8.13.2. Financial Performance 17
        8.13.3. Product Benchmarking 17
        8.13.4. Strategic Initiatives 17
    8.14. Mitomics 17
        8.14.1. Company Overview 17
        8.14.2. Financial Performance 17
        8.14.3. Product Benchmarking 17
        8.14.4. Strategic Initiatives 17
    8.15. Sanarus Technologies 17
        8.15.1. Company Overview 18
        8.15.2. Financial Performance 18
        8.15.3. Product Benchmarking 18
        8.15.4. Strategic Initiatives 18
    8.16. Verna Medical Technologies 18
        8.16.1. Company Overview 18
        8.16.2. Financial Performance 18
        8.16.3. Product Benchmarking 18
        8.16.4. Strategic Initiatives 18
    8.17. Inrad Inc. 18
        8.17.1. Company Overview 18
        8.17.2. Financial Performance 18
        8.17.3. Product Benchmarking 18
        8.17.4. Strategic Initiatives 18
    8.18. UK Biopsy 18
        8.18.1. Company Overview 18
        8.18.2. Financial Performance 18
        8.18.3. Product Benchmarking 18
        8.18.4. Strategic Initiatives 18
    8.19. Intuitive 18
        8.19.1. Company Overview 18
        8.19.2. Financial Performance 18
        8.19.3. Product Benchmarking 18
        8.19.4. Strategic Initiatives 18

TABLE # 1 GLOBAL BIOPSY DEVICES MARKET BY PRODUCT 2012 – 2022 ($ BILLION) 18
TABLE # 2 GLOBAL NEEDLE-BASED BIOPSY GUNS 2012 – 2022 ($ BILLION) 18
TABLE # 3 GLOBAL VACUUM-ASSISTED BIOPSY (VAB) DEVICES 2012 – 2022 ($ BILLION) 19
TABLE # 4 GLOBAL CORE NEEDLE BIOPSY (CNB) DEVICES 2012 – 2022 ($ BILLION) 19
TABLE # 5 GLOBAL FINE NEEDLE ASPIRATION BIOPSY (FNAB) DEVICES 2012 – 2022 ($ BILLION) 19
TABLE # 6 GLOBAL BIOPSY NEEDLES 2012 – 2022 ($ BILLION) 19
TABLE # 7 GLOBAL DISPOSABLE BIOPSY NEEDLES 2012 – 2022 ($ BILLION) 19
TABLE # 8 GLOBAL REUSABLE BIOPSY NEEDLES 2012 – 2022 ($ BILLION) 19
TABLE # 9 GLOBAL BIOPSY FORCEPS 2012 – 2022 ($ BILLION) 19
TABLE # 10 GLOBAL COLD (GENERAL) BIOPSY FORCEPS 2012 – 2022 ($ BILLION) 19
TABLE # 11 GLOBAL HOT BIOPSY FORCEPS 2012 – 2022 ($ BILLION) 19
TABLE # 12 GLOBAL BIOPSY GUIDANCE SYSTEMS 2012 – 2022 ($ BILLION) 19
TABLE # 13 GLOBAL MANUAL GUIDANCE SYSTEMS 2012 – 2022 ($ BILLION) 19
TABLE # 14 GLOBAL ROBOTIC GUIDANCE SYSTEMS 2012 – 2022 ($ BILLION) 19
TABLE # 15 GLOBAL OTHERS 2012 – 2022 ($ BILLION) 19
TABLE # 16 GLOBAL BIOPSY BRUSHES 2012 – 2022 ($ BILLION) 19
TABLE # 17 GLOBAL BIOPSY CURETTES 2012 – 2022 ($ BILLION) 19
TABLE # 18 GLOBAL BIOPSY PUNCHES 2012 – 2022 ($ BILLION) 19

FIGURE # 1 GLOBAL BIOPSY INDUSTRY MARKET SHARE 2012 - 2022 ($ BILLION) 19
FIGURE # 2 MARKET SHARE BY REGIONS 19
FIGURE # 3 UNITED STATES MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 19
FIGURE # 4 CANADA MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 5 MEXICO MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 6 UK MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 7 FRANCE MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 8 GERMANY MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 9 APAC MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 10 CHINA MARKET ESTIMATES AND FORECAST 2012 – 2022($ BILLION) 20
FIGURE # 11 INDIA MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 13 CENTRAL & SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20
FIGURE # 14 BRAZIL MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 20

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)